TLRT/
Editorial Board

Editorial Board

  • Editor-in-Chief

    • Prof.  Rüdiger Hehlmann

      Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany.

      Research Interests: hematology; leukemia; chronic myeloid leukemia (CML).

      avatar img

  • Associate Editors-in-Chief

    • Dr.  Hagop Kantarjian, M.D.

      Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

      Research Interests: AML; ALL; CML; clinical trials.

      avatar img

    • Prof.  Courtney D. DiNardo, MD, MSCE

      Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

      Research Interests: AML; clinical trials; targeted therapeutics; hereditary leukemias; prognostication.

      avatar img

    • Prof.  Matteo Giovanni Della Porta

      Cancer Center, Humanitas Research Hospital & Dept. of Biomedical Sciences, Humanitas University, Milan, Italy.

      Research Interests: molecular hematology; myeloid neoplasms; artificial intelligence.

      avatar img

  • Editorial Board Members

    • Prof.  Hans-Jochem Kolb

      LMU, TUM, München Klinik, München, Germany.

      Research Interests: stem cell; transplantation; hematology; oncology radiobiology and immunology.

      avatar img

    • Prof.  Dennis Kim

      • 1. Princess Margaret Cancer Centre/University Health Network, Toronto, Canada.
      • 2. University of Toronto, Toronto, Canada.

      Research Interests: genomics; acute Leukemia; chronic myeloid leukemia; minimal residual disease monitoring; post-transplant relapse; graft-versus-host disease.

      avatar img

    • Assoc. Prof.  Laurent Garderet

      Sorbonne Université, Paris, France.

      Research Interests: myeloma; AL amyloidosis; transplantation.

      avatar img

    • Prof.  Jeffrey H. Lipton, PhD MD FRCPC

      Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.

      Research Interests: chronic myeloid leukemia; allogeneic stem cell transplantation; bone marrow failure syndromes.

      avatar img

    • Prof.  Arnon Nagler, MD, Msc

      • 1. President Hemato-oncology Center, Chaim Sheba Medical Center, Tel Hashomer, Israel.
      • 2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

      Research Interests: cord blood biology; adoptive cell mediated immunotherapy NK and CTL activity; transplantation in hemato-oncological malignancies; fibrotic disorders and the role of collagen type I.

      avatar img

    • Prof.  Tapani Ruutu

      Clinical Research Institute, Helsinki University Hospital, Helsinki, Finland.

      Research Interests: hematopoietic stem cell transplantation; acute leukemia; myelodysplastic syndromes.

      avatar img

    • Prof.  Qian Jiang

      Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.

      Research Interests: chronic myeloid leukemia; acute myeloid leukemia; myeloproliferative neoplasms; Ph-positive leukemia; tyrosine kinase inhibitors.

      avatar img